SHELBY WROBLEWSKI: Open Payments
NPI 1366175705 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 26 payments from 11 companies in 2025. Trend: 2023 $557 · 2024 $707 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $235 |
| United Therapeutics Corporation | 3 | $64 |
| Inspire Medical Systems, Inc. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Tactile Systems Technology Inc | 1 | $26 |
| Insmed, Inc. | 1 | $25 |
| Verona Pharma, Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
Products named: NUCALA, INSPIRE, TRELEGY ELLIPTA, Tyvaso, AIRSUPRA, WINREVAIR, GLASSIA, Remodulin.
Industry payments across OH — which companies pay providers there.
